港股午評：科技股齊挫，恆指跌1.62%，恆生科指再度失守4500點
格隆匯3月25日丨港股臨近午盤跳水下跌，恆指跌1.62%下挫355點，恆生科技指數跌2.57%，再度失守4500點關口。南下資金半日淨流入5.98億港元，大市成交額為721億港元。
盤面上，大型科技股齊挫，美團跌6%，網易、阿里巴巴、快手、百度均跌超3%，騰訊跌近2%；互聯網醫療股、海運股、電力股、體育用品股、汽車股、家電股、教育股、餐飲股、煤炭股、有色金屬股紛紛走低，平安好醫生重挫逾9%，長城汽車跌超6%。 另一方面，惟濠賭股、香港本地板塊少數上漲，新鴻基地產、恆生銀行逆勢飄紅。
航運股走弱，運價持續兩個月走低，俄烏戰爭和中國疫情讓淡季更淡。每年首季是航運淡季，近2個月航運運價走跌，加上近期受俄烏戰爭、中國爆發本土疫情等影響，導致港口出貨不順而產生遞延效果，淡季比原本更淡。
濠賭股多數上漲，珠澳口岸入境核檢續評估放寬至48小時可行性。澳門特區新型冠狀病毒感染應變協調中心表示，考慮到珠海近日已沒有社區的本地個案，其最後一宗本地個案是3月19日，應變協調中心會持續評估，並與珠海相關部門保持密切溝通，評估是否在最後一宗本地個案後七天，將珠澳口岸入境核酸檢測陰性證明的要求由24小時變為48小時的可行性，有進一步消息將盡快公佈。
瑞聲科技(2018.HK)逆勢漲5.33%，機構依然看好其增長前景。大和發研報指，公司2021年第四季度的業績表現不佳，但符合盈利預警，依然看好瑞聲科技的增長前景。 此外，公司還與中國頂級汽車供應商合作提供聲學解決方案，並計劃從2023年初開始出貨。該行重申其“買入”評級。
俄鋁(0486.HK)跌超4%，盤中一度拉昇漲超8%。消息面上，美國最新宣佈對400餘個俄羅斯個人和實體實施制裁，其中不包括俄鋁。
醫脈通(2192.HK)跌超17%，年度純利下降52.3%至4061.6萬元。該公司昨日發佈財報，截至2021年12月31日止12個月，公司收益為2.84億元(人民幣,下同)，同比增長33.2%；母公司擁有人應占溢利為4061.6萬元，同比下降52.3%；每股基本盈利6.59分。董事會決議建議末期股息每股股份人民幣0.0170元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
